Optimization of the Macrocyclic Tetrapeptide [D-Trp]CJ-15,208 to Prevent Stress-Induced Relapse of Cocaine-Seeking Behavior
Authors:
- Jane V. AldrichJAJane V. Aldrich
- Dmitry Y. YakovlevDYDmitry Y. Yakovlev
- Jeremy S. ColemanJCJeremy S. Coleman
- Sanjeewa N. SenadheeraSSSanjeewa N. Senadheera
- Heather M. StacyHSHeather M. Stacy
- Shainnel O. EansSEShainnel O. Eans
- Brian I. KnappBKBrian I. Knapp
- Jean M. BidlackJBJean M. Bidlack
- Jay P. McLaughlinJay P. McLaughlin
Open Access
Abstract
Kappa opioid receptor (KOR) antagonists may have therapeutic potential to prevent stress-induced relapse in abstinent individuals with cocaine use disorder (CUD). The macrocyclic peptide [D-Trp]CJ-15,208 (cyclo[Phe-D-Pro-Phe-D-Trp]) is an orally bioavailable, brain–penetrant selective KOR antagonist that prevents stress-induced reinstatement of cocaine-seeking behavior in a mouse model of CUD. We synthesized and evaluated analogs of this lead compound with substitutions for the D-Trp residue to identify analogs that exhibit more potent central KOR antagonism following oral administration. The peptides were synthesized by a combination of solid phase and solution peptide synthetic methodologies, and their pharmacological activity was evaluated both in vitro (for KOR affinity, selectivity and antagonism) and in vivo (for antinociception and KOR antagonism), with promising analogs evaluated for their ability to prevent stress-induced reinstatement of cocaine-seeking behavior in the mouse conditioned place preference (CPP) assay. A variety of substituted D-Phe or modified D-Trp derivatives were tolerated by KOR with retention of significant KOR antagonism in vivo after oral administration. Macrocyclic peptide pretreatment, per os, significantly prevented stress-induced reinstatement of cocaine CPP at doses of 10 and 30 mg/kg of [D-Phe4]CJ-15,208, 4, and 30 mg/kg of [D-Trp(formamide)]CJ-15,208, 3, which are 6-fold and 2-fold lower, respectively, than that needed for {D-Trp]CJ-15,208.Keywords
Funding Information
- National Institutes of Health (UG3 NS132600, UH3 NS132600)
- Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (W8lXWH-15-1-0452, W8lXWH-15-1-0464)
This publication has 47 references indexed in Scilit:
- Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorderEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAsMolecular Therapy Nucleic Acids, 2022
- Dynorphin/Kappa Opioid Receptor Activity Within the Extended Amygdala Contributes to Stress-Enhanced Alcohol Drinking in MiceBiological Psychiatry, 2022
- Protracted withdrawal from ethanol and enhanced responsiveness stress: Regulation via the dynorphin/kappa opioid receptor systemAlcohol, 2013
- Sex differences in kappa opioid pharmacologyLife Sciences, 2011
- Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynEuropean Journal of Pharmacology, 2007
- Stress-Induced Cocaine Craving and Hypothalamic-Pituitary-Adrenal Responses Are Predictive of Cocaine Relapse OutcomesArchives of General Psychiatry, 2006
- Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strainsPsychopharmacology, 2005
- Stress-induced craving and stress response in cocaine dependent individualsPsychopharmacology, 1999
- Conditioned place preference using opiate and stimulant drugs: A meta-analysisNeuroscience & Biobehavioral Reviews, 1995